483 related articles for article (PubMed ID: 14648664)
21. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
22. FGF4 and INT2 oncogenes are amplified and expressed in Kaposi's sarcoma.
Kiuru-Kuhlefelt S; Sarlomo-Rikala M; Larramendy ML; Söderlund M; Hedman K; Miettinen M; Knuutila S
Mod Pathol; 2000 Apr; 13(4):433-7. PubMed ID: 10786811
[TBL] [Abstract][Full Text] [Related]
23. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.
Yuan BZ; Zhou X; Zimonjic DB; Durkin ME; Popescu NC
J Mol Diagn; 2003 Feb; 5(1):48-53. PubMed ID: 12552080
[TBL] [Abstract][Full Text] [Related]
24. Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma.
Lázár V; Ecsedi S; Szöllosi AG; Tóth R; Vízkeleti L; Rákosy Z; Bégány A; Adány R; Balázs M
Mod Pathol; 2009 Oct; 22(10):1367-78. PubMed ID: 19633643
[TBL] [Abstract][Full Text] [Related]
25. A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas.
Schneeberger C; Eder S; Swoboda H; Ullrich R; Zeillinger R
Oral Oncol; 1998 Jul; 34(4):257-60. PubMed ID: 9813719
[TBL] [Abstract][Full Text] [Related]
26. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
27. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization.
Weiss MM; Snijders AM; Kuipers EJ; Ylstra B; Pinkel D; Meuwissen SG; van Diest PJ; Albertson DG; Meijer GA
J Pathol; 2003 Jul; 200(3):320-6. PubMed ID: 12845628
[TBL] [Abstract][Full Text] [Related]
28. [Demonstration of gene amplification in urinary bladder cancer by fluorescent in situ hybridization (FISH)].
Sauter G; Moch H; Gudat F; Mihatsch MJ; Haley J; Meecker T; Waldman F
Verh Dtsch Ges Pathol; 1993; 77():247-51. PubMed ID: 7511290
[TBL] [Abstract][Full Text] [Related]
29. Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma.
Hui AB; Or YY; Takano H; Tsang RK; To KF; Guan XY; Sham JS; Hung KW; Lam CN; van Hasselt CA; Kuo WL; Gray JW; Huang DP; Lo KW
Cancer Res; 2005 Sep; 65(18):8125-33. PubMed ID: 16166286
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J
Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641
[TBL] [Abstract][Full Text] [Related]
31. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
Champème MH; Bièche I; Hacène K; Lidereau R
Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
[TBL] [Abstract][Full Text] [Related]
32. Co-overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma.
Tai AL; Sham JS; Xie D; Fang Y; Wu YL; Hu L; Deng W; Tsao GS; Qiao GB; Cheung AL; Guan XY
Cancer; 2006 Jan; 106(1):146-55. PubMed ID: 16329133
[TBL] [Abstract][Full Text] [Related]
33. FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma.
Arao T; Ueshima K; Matsumoto K; Nagai T; Kimura H; Hagiwara S; Sakurai T; Haji S; Kanazawa A; Hidaka H; Iso Y; Kubota K; Shimada M; Utsunomiya T; Hirooka M; Hiasa Y; Toyoki Y; Hakamada K; Yasui K; Kumada T; Toyoda H; Sato S; Hisai H; Kuzuya T; Tsuchiya K; Izumi N; Arii S; Nishio K; Kudo M
Hepatology; 2013 Apr; 57(4):1407-15. PubMed ID: 22890726
[TBL] [Abstract][Full Text] [Related]
34. Analysis of chromosomal aberrations involving chromosome 1q31-->q53 in a DMBA-induced rat fibrosarcoma cell line: amplification and overexpression of Jak2.
Sjöling A; Lindholm H; Samuelson E; Yamasaki Y; Watanabe TK; Tanigami A; Levan G
Cytogenet Cell Genet; 2001; 95(3-4):202-9. PubMed ID: 12063401
[TBL] [Abstract][Full Text] [Related]
35. Evolutionary conservation of CCND1-ORAOV1-FGF19-FGF4 locus from zebrafish to human.
Katoh M; Katoh M
Int J Mol Med; 2003 Jul; 12(1):45-50. PubMed ID: 12792807
[TBL] [Abstract][Full Text] [Related]
36. MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas.
Janssen JW; Imoto I; Inoue J; Shimada Y; Ueda M; Imamura M; Bartram CR; Inazawa J
J Hum Genet; 2002; 47(9):460-4. PubMed ID: 12202983
[TBL] [Abstract][Full Text] [Related]
37. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN
Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462
[TBL] [Abstract][Full Text] [Related]
38. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
[TBL] [Abstract][Full Text] [Related]
39. [The clinical significance of expression and amplification of FGF3 in bladder transitional cell carcinoma].
Zhang YH; Xie D; Luo JH; Chen W; Chen LW; Xu QC
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2556-9. PubMed ID: 17198565
[TBL] [Abstract][Full Text] [Related]
40. Amplification of CCND1, EMS1, PIK3CA, and ERBB oncogenes in ethmoid sinus adenocarcinomas.
Nazar G; González MV; García JM; Llorente JL; Rodrigo JP; Suárez C
Otolaryngol Head Neck Surg; 2006 Jul; 135(1):135-9. PubMed ID: 16815198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
